Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis

Näslund-Koch C, Zachariae C, Skov L

Therapeutics and Clinical Risk Management 2020, 16:903-916

Published Date: 24 September 2020